18. Tumor Immunology and Immunotherapy Flashcards
What is the relationship between immune surveillance and immunoediting?
Tumor immunoediting involves the elimination of tumor cells by immune surveillance
What would an increasing level of a tumor associated antigen indicate about a cancer patient undergoing chemotherapy?
An increasing level would indicate that the chemotherapy is not successful/effective.
What type(s) of tumors is Alpha-1-Fetoprotein (AFP) associated with?
Primarily testicular and hepatocellular
What type(s) of tumors is CA 125 associated with?
primarily ovarian
What cells are involved in nonspecific immune responses to tumor cells?
- NK cells
- LAK cells
- Macrophages
What cells are involved in specific immune responses to tumor cells?
- CTL-mediated (involves APC, T helper, and CTL)
- Antibody dependent cell-mediated (involves NK cell and macrophages)
Which cytokine is released by macrophages in the nonspecific response to tumors, and how does it function?
- lysosomal enzymes, reactive oxygen species, and TNF-alpha are released from macrophage.
- TNF-alpha has cytotoxic effects on tumor cells
What role do antibodies play in the immune response to tumor cells?
Antibody Dependent Cell-Mediated Cytotoxicity (ADCC)
- involves antibody to tumor Ag
- Ab -> Ag, FcR on NK or macrophage -> Fc portion of Ab -> release of enzymes -> tumor cell destroyed
What are 4 ways in which a tumor cell can evade the immune response?
- Alteration of tumor antigens or other surface markers
- Antigen masking
- APC may fail to adequately present tumor antigens to T cells
- Suppression of the immune response
What cytokines have been used to treat tumors and what are their modes of action?
- Interferons alpha, beta, and gamma
Mechanism: Destruction of virus-infected cells, enhancement of macrophage and NK function, increase of MHC antigen expression - IL-2
Mechanism: stimulates proliferation of activated T helper cells, induces maturation of CTL
Which cytokine is used to generate LAK cells for use in adaptive immunotherapy?
Incubation of tumor-infiltrating cells (TIL) or lymphocytes from peripheral blood with IL-2